This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Europe
Mark Your Calendar for BPI Europe 2023!
9-12 May 2023RAI in Amsterdam

Kyle Zingaro
Head of Gene Therapy Drug Substance Process Sciences at UCB


Kyle has 10+ years of experience leading technical and operational teams in preclinical through post-commercial development of biologics. Kyle is the UCB Head of Gene Therapy Drug Substance Process Sciences where he is accountable for leading the internal and external development of the manufacturing processes for UCBs gene therapy portfolio.

Prior to joining UCB, Kyle was Head of Process Sciences at Thermo Fisher Scientific Viral Vector Services (formerly Brammer Bio) where he was responsible for leading commercial stage tech transfer and late-phase process development of Thermo Fisher's cell & gene therapy offerings. He holds a B.S. in biochemistry from Virginia Tech and a Ph.D. in chemical engineering from University of Delaware

Agenda Sessions

  • Building Platforms, Organizations, & CDMO Networks for a Full Gene Therapy Product Lifecycle